摘要
目的探讨醒脾祛瘀通脉汤联合甲磺酸倍他司汀治疗良性阵发性位置性眩晕的临床效果。方法选取2018年11月—2020年12月河南省某医院收治的60例良性阵发性位置性眩晕患者,采用随机数字表法分为对照组和观察组,每组30例。对照组患者采用甲磺酸倍他司汀片治疗,观察组患者在对照组基础上联用醒脾祛瘀通脉汤治疗,比较2组患者的临床疗效及治疗前后中医证候积分及眩晕障碍量表(DHI)评分。结果观察组患者治疗总有效率为96.67%,高于对照组的73.33%,差异有统计学意义(P<0.05)。治疗前,2组患者中医证候积分比较,差异无统计学意义(P>0.05);治疗后,2组患者视物旋转、头重如裹、恶心呕吐、胸闷4项证候积分低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。治疗前,2组患者眩晕障碍程度比较,差异无统计学意义(P>0.05);治疗后,2组患者DHI量表中躯体、情绪、功能3个维度评分及总分低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。结论醒脾祛瘀通脉汤联合甲磺酸倍他司汀片治疗良性阵发性位置性眩晕疗效确切,有助于促进症状及体征消除,值得推广。
Objective To explore the clinical effect of Xingpi Quyu Tongmai decoction combined with betahistine mesylate in the treatment of benign paroxysmal positional vertigo.Methods A total of 60 patients with benign paroxysmal positional vertigo treated in a hospital in Henan Province from November 2018 to December 2020 were randomly divided into control group and observation group,with 30 cases in each group.Patients in the control group were treated with betastine mesylate tablets,and observation group were treated with Xingpi Quyu Tongmai decoction on the basis of the control group.The clinical efficacy,TCM syndrome score and dizziness handicap inventory(DHI)before and after treatment were compared between the two groups.Results The total effective rate of the observation group was 96.67%,which was higher than that of the control group(73.33%),and the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in TCM syndrome scores between the two groups(P>0.05).After treatment,the syndrome scores of visual rotation,head weight,nausea,vomiting and chest tightness in the two groups were lower than those before treatment;and those in the observation group were lower than those in the control group;the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in the degree of vertigo between the two groups(P>0.05).After treatment,the scores and total scores of body,emotion and function in the DHI among the two groups were lower than those before treatment;and those in the observation group were lower than those in the control group;the difference was statistically significant(P<0.05).Conclusion Xingpi Quyu Tongmai decoction combined with betahistine mesylate tablets is effective in the treatment of benign paroxysmal positional vertigo,and could help to promote the elimination of symptoms and signs,which is worth popularizing.
作者
张珍
任希
王醒哲
Zhang Zhen;Ren Xi;Wang Xingzhe(Department of Geriatrics,Yingyang Hospital of Traditional Chinese Medicine,Yingyang Henan 450100,China)
出处
《保健医学研究与实践》
2021年第5期119-122,共4页
Health Medicine Research and Practice
